Five Prime Therapeutics, Inc. was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $3.83 – $5.46 in the past one-month time frame, witnessed a sharp increase on Friday.
 
The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Five Prime. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Five Prime currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive. 

Five Prime Therapeutics, Inc. Price

Five Prime Therapeutics, Inc. price | Five Prime Therapeutics, Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider QIAGEN N.V. (QGEN Quick QuoteQGEN - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks’ 2020 Election Stock Report

In addition to the companies you learned about above, we invite you to learn more about profiting from the upcoming presidential election. Trillions of dollars will shift into new market sectors after the votes are tallied, and investors could see significant gains. This report reveals specific stocks that could soar: 6 if Trump wins, 6 if Biden wins.

Check out the 2020 Election Stock Report >>